logo
ANHUI BBCA PHARMACEUTICAL CO.,LTD
ANHUI BBCA PHARMACEUTICAL CO.,LTD
productos
En casa /

productos

White tablet ,Antipyretic and analgesic medicine

Detalles del producto

Lugar de origen: PORCELANA

Nombre de la marca: BBCA

Certificación: GMP

Número de modelo: Comprimidos 500 mg

Condiciones de pago y envío

Cantidad de orden mínima: 500 millones de tabletas

Precio: $2.9/1000tablets

Detalles de empaquetado: 10*10 tabletas/ caja, 100*10 tabletas/ caja, o según el cliente

Tiempo de entrega: 45 días de trabajo

Condiciones de pago: T/T, L/C

Capacidad de la fuente: 10 millones/día

Obtenga el mejor precio
Contacta ahora
Especificaciones
Resaltar:

white antipyretic analgesic tablet

,

antipyretic analgesic pharmaceutical tablet

,

white pain relief medicine tablet

Color:
comprimido blanco
Almacenamiento:
Conservar en un lugar fresco y seco a menos de 25°C proteger de la luz
Embalaje:
10*10 tabletas/ caja, 100*10 tabletas/ caja, o según el cliente
Forma de dosis:
Tableta
SPE:
500 mg por día
Origen:
PORCELANA
Ingrediente activo:
Paracetamol
Color:
comprimido blanco
Almacenamiento:
Conservar en un lugar fresco y seco a menos de 25°C proteger de la luz
Embalaje:
10*10 tabletas/ caja, 100*10 tabletas/ caja, o según el cliente
Forma de dosis:
Tableta
SPE:
500 mg por día
Origen:
PORCELANA
Ingrediente activo:
Paracetamol
Descripción
White tablet ,Antipyretic and analgesic medicine
Antipyretic and analgesic

This is antipyretic analgesic medicine, It is white crystal or crystalline powder; Odorless, slightly bitter taste. For fever, can also be used to relieve mild to moderate pain, such as headache, muscle pain, joint pain and neuralgia, dysmenorrhea, cancer pain and postoperative pain.

 

It is easy to absorb orally, the blood concentration reaches a peak of 0.5~1h, 95% is inactivated by combination with glucuronic acid or sulfuric acid in the body, and 5% is converted into metabolites that are toxic to the liver by hydroxylation, all of which are discharged from the urine. The plasma protein binding rate was 25%. 90% to 95% are metabolized in the liver, and are mainly combined with glucuronic acid, sulfuric acid and cysteine. Intermediate metabolites have toxic effects on the liver. T1/2 is generally 1 to 4 hours (average 2 hours), and renal insufficiency is unchanged, but it may be prolonged in some liver disease patients, the elderly and newborns can be prolonged, and children are shortened. This product is mainly excreted from the kidneys in the form of glucuronic acid binding, and about 3% is excreted in urine in its original form within 24 hours.

 

Contact way:

Email:nancyzhu@bbcapharma.com

Mp / WhatsApp / Wechat: 0086-139 6507 2522

Envíe su consulta
Envíenos su solicitud y le responderemos lo antes posible.
Envío